Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Other Non-Current Liabilities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $1.7 million as the latest value for Q1 2026.

  • Quarterly Other Non-Current Liabilities rose 2196.05% to $1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Jan 2026, up 2196.05% year-over-year, with the annual reading at $140000.0 for FY2025, 84.21% up from the prior year.
  • Other Non-Current Liabilities for Q1 2026 was $1.7 million at Kestra Medical Technologies, up from $140000.0 in the prior quarter.
  • The five-year high for Other Non-Current Liabilities was $5.2 million in Q3 2025, with the low at $76000.0 in Q2 2024.
  • Average Other Non-Current Liabilities over 3 years is $1.2 million, with a median of $140000.0 recorded in 2025.
  • The sharpest move saw Other Non-Current Liabilities soared 84.21% in 2025, then surged 2196.05% in 2026.
  • Over 3 years, Other Non-Current Liabilities stood at $76000.0 in 2024, then skyrocketed by 84.21% to $140000.0 in 2025, then soared by 1146.43% to $1.7 million in 2026.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods came in at $1.7 million, $140000.0, and $5.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.